Abiopharma

🔍 Kitayama Mitchell W (Director)

Company: Astrana Health, Inc. (ASTH)

Report Date: 2026-06-10

Detailed Transactions and Holdings:

• Acquired 4,991 shares of Common Stock (Direct)
  Date: 2026-06-10 | Code: A | equity_swap_involved: 0 | shares_owned_after: 32,837.00 | transaction_form_type: 4 | Footnotes: F1, F2

Footnotes:

• F1: Restricted shares of the Issuer's common stock granted pursuant to the Issuer's 2024 Equity Incentive Plan, which will vest on the earlier of (i) June 10, 2027 or (ii) the date of the Issuer's 2027 annual meeting of stockholders.
• F2: Includes 4,991 shares of restricted stock, which will vest on the earlier of June 10, 2027 or the date of the Issuer's 2027 annual meeting of stockholders.